Cargando…

Complement Component 3 Negatively Regulates Antibody Response by Modulation of Red Blood Cell Antigen

Red blood cell (RBC) alloimmunization can make it difficult to procure compatible RBCs for future transfusion, directly leading to increased morbidity and mortality in transfusion-dependent patients. However, the factors that regulate RBC alloimmunization remain incompletely understood. As complemen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mener, Amanda, Arthur, Connie M., Patel, Seema R., Liu, Jingchun, Hendrickson, Jeanne E., Stowell, Sean R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004516/ https://www.ncbi.nlm.nih.gov/pubmed/29942300 http://dx.doi.org/10.3389/fimmu.2018.00676

Ejemplares similares

Fc Gamma Receptors and Complement Component 3 Facilitate Anti-fVIII Antibody Formation
por: Zerra, Patricia E., et al.
Publicado: (2020)

CD4 Depletion or CD40L Blockade Results in Antigen-Specific Tolerance in a Red Blood Cell Alloimmunization Model
por: Natarajan, Prabitha, et al.
Publicado: (2017)

Complement Plays a Critical Role in Inflammation-Induced Immunoprophylaxis Failure in Mice
por: Escamilla-Rivera, Vicente, et al.
Publicado: (2021)

The Development and Consequences of Red Blood Cell Alloimmunization
por: Arthur, Connie M., et al.
Publicado: (2023)

Marginal Zone B Cells Induce Alloantibody Formation Following RBC Transfusion
por: Patel, Seema R., et al.
Publicado: (2018)

Initiation and Regulation of Complement during Hemolytic Transfusion Reactions
por: Stowell, Sean R., et al.
Publicado: (2012)

Antibodies to Senescent Antigen and C3 Are Not Required for Normal Red Blood Cell Lifespan in a Murine Model
por: Hudson, Krystalyn E., et al.
Publicado: (2017)

FcγRIV is required for IgG2c mediated enhancement of RBC alloimmunization
por: Qiu, Annie, et al.
Publicado: (2022)

Innate B-1 B Cells Are Not Enriched in Red Blood Cell Autoimmune Mice: Importance of B Cell Receptor Transgenic Selection
por: Richards, Amanda L., et al.
Publicado: (2017)

Bridging channel dendritic cells induce immunity to transfused red blood cells
por: Calabro, Samuele, et al.
Publicado: (2016)

Neutralizing Antibodies Against Factor VIII Can Occur Through a Non-Germinal Center Pathway
por: Patel, Seema R., et al.
Publicado: (2022)

QUANTITATIVE CHEMICAL STUDIES ON COMPLEMENT OR ALEXIN : II. THE INTERRELATION OF COMPLEMENT WITH ANTIGEN-ANTIBODY COMPOUNDS AND WITH SENSITIZED RED CELLS
por: Heidelberger, Michael, et al.
Publicado: (1941)

The Sweet-Side of Leukocytes: Galectins as Master Regulators of Neutrophil Function
por: Robinson, Brian S., et al.
Publicado: (2019)

Red blood cell alloimmunization and sickle cell disease: a narrative review on antibody induction
por: Hendrickson, Jeanne E.
Publicado: (2020)

A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein
por: Yatime, Laure, et al.
Publicado: (2018)

Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway
por: Macedo, Ana Catarina Lunz, et al.
Publicado: (2016)

The Interactions of Parasite Calreticulin With Initial Complement Components: Consequences in Immunity and Virulence
por: Ramírez-Toloza, Galia, et al.
Publicado: (2020)

Properdin Is a Key Player in Lysis of Red Blood Cells and Complement Activation on Endothelial Cells in Hemolytic Anemias Caused by Complement Dysregulation
por: Chen, Jin Y., et al.
Publicado: (2020)

In Vitro and In Vivo Differences in Murine Third Complement Component (C3) Opsonization and Macrophage/Leukocyte Responses to Antibody-Functionalized Iron Oxide Nanoworms
por: Wang, Guankui, et al.
Publicado: (2017)

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity
por: Kurtovic, Liriye, et al.
Publicado: (2021)

Early Components of the Complement Classical Activation Pathway in Human Systemic Autoimmune Diseases
por: Lintner, Katherine E., et al.
Publicado: (2016)

Be on Target: Strategies of Targeting Alternative and Lectin Pathway Components in Complement-Mediated Diseases
por: Dobó, József, et al.
Publicado: (2018)

Complement Component C1q as Serum Biomarker to Detect Active Tuberculosis
por: Lubbers, Rosalie, et al.
Publicado: (2018)

Activation of Complement Components on Circulating Blood Monocytes From COVID-19 Patients
por: Lage, Silvia Lucena, et al.
Publicado: (2022)

Weak Expression of Terminal Complement in Active Antibody-Mediated Rejection of the Kidney
por: Tiller, Gesa, et al.
Publicado: (2022)

Factor H Autoantibodies and Complement-Mediated Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2020)

Complement Factor I Variants in Complement-Mediated Renal Diseases
por: Zhang, Yuzhou, et al.
Publicado: (2022)

Molecular Characterization of Complement Component 3 (C3) in the Pearl Oyster Pinctada fucata Improves Our Understanding of the Primitive Complement System in Bivalve
por: Wang, Zhongliang, et al.
Publicado: (2021)

Anti-complement 5 antibody ameliorates antibody-mediated rejection after liver transplantation in rats
por: Tajima, Tetsuya, et al.
Publicado: (2023)

Association of complement components with the risk and severity of NAFLD: A systematic review and meta-analysis
por: Zhao, Jianbo, et al.
Publicado: (2022)

Complement Component C4 Regulates the Development of Experimental Autoimmune Uveitis through a T Cell-Intrinsic Mechanism
por: Zhang, Lingjun, et al.
Publicado: (2017)

Complement Inhibition in Severe COVID-19 Acute Respiratory Distress Syndrome
por: Raghunandan, Sharmila, et al.
Publicado: (2020)

Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
por: Tang, Guo-Qing, et al.
Publicado: (2023)

Beyond Binding: The Outcomes of Antibody-Dependent Complement Activation in Human Malaria
por: Rathnayake, Dilini, et al.
Publicado: (2021)

IgG Suppresses Antibody Responses to Sheep Red Blood Cells in Double Knock-Out Mice Lacking Complement Factor C3 and Activating Fcγ-Receptors
por: Anania, Jessica C., et al.
Publicado: (2020)

Corrigendum: Zilucoplan, a macrocyclic peptide inhibitor of human complement component 5, uses a dual mode of action to prevent terminal complement pathway activation
por: Tang, Guo-Qing, et al.
Publicado: (2023)

Complement Component C1q Programs a Pro-Efferocytic Phenotype while Limiting TNFα Production in Primary Mouse and Human Macrophages
por: Hulsebus, Holly J., et al.
Publicado: (2016)

Monoclonal Antibodies Capable of Inhibiting Complement Downstream of C5 in Multiple Species
por: Zelek, Wioleta M., et al.
Publicado: (2020)

SARS-CoV-2 Antibodies Mediate Complement and Cellular Driven Inflammation
por: Jarlhelt, Ida, et al.
Publicado: (2021)

Macrophages regulate gastrointestinal motility through complement component 1q
por: Pendse, Mihir, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t578p84ja1gk0ag8qece3rgla3